Skip to content

Albert Ying-Hwa Liu, MD

NPI 1326153768ActiveIndividual· Internal Medicine· San Francisco, CA

Internal Medicine (MD) in San Francisco, California, licensed in CA, with an NPI issued in August 2006. Part D covered 23 prescriptions written in 2024, 78% of them generic. Gilead Sciences, Inc. was the largest of 4 companies reporting payments in 2025, $3,952 in all, mostly consulting fees.

Overview

NPI1326153768
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 19, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XA75174CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)23 · 28 30-day fills
Total drug cost$13,897
Generic share78% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$3,952 · 13 payments from 4 companies
  • 2024$2,939 · 35 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Gilead Sciences, Inc.$3,3801
Abbott Laboratories$343.0510
Ebr Systems, Inc.$199.141
Cardiva Medical, Inc.$29.321

What the 2025 payments were for

  • Consulting Fee$3,380 · 1 payment
  • Food and Beverage$571.51 · 12 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in San Francisco

All Internal Medicine providers in California →